Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Trans R Soc Trop Med Hyg ; 110(12): 690-695, 2016 12 01.
Article in English | MEDLINE | ID: mdl-28938053

ABSTRACT

Background: Among the 216 districts in Ghana, 98 were declared endemic for lymphatic filariasis in 1999 after mapping. Pursuing the goal of elimination, WHO recommends annual treatment using mass drugs administration (MDA) for at least 5 years. MDA was started in the country in 2001 and reached national coverage in 2006. By 2014, 69 districts had 'stopped-MDA' (after passing the transmission assessment survey) while 29 others remained with persistent microfilaraemia (mf) prevalence (≥1%) despite more than 11 years of MDA and were classified as 'hotspots'. Methods: An ecological study was carried out to compare baseline mf prevalence and anti-microfilaria interventions between hotspot and stopped-MDA districts. Results: Baseline mf prevalence was significantly higher in hotspots than stopped-MDA districts (p<0.001). After three years of MDA, there was a significant decrease in mf prevalence in hotspot districts, but it was still higher than in stopped-MDA districts. The number of MDA rounds was slightly higher in hotspot districts (p<0.001), but there were no differences in coverage of MDA or long-lasting-insecticide-treated nets. Conclusions: The main difference in hotspots and stopped-MDA districts was a high baseline mf prevalence. This finding indicates that the recommended 5-6 rounds annual treatment may not achieve interruption of transmission.


Subject(s)
Elephantiasis, Filarial/drug therapy , Elephantiasis, Filarial/epidemiology , Endemic Diseases/prevention & control , Endemic Diseases/statistics & numerical data , Filaricides/administration & dosage , Mass Drug Administration/statistics & numerical data , Animals , Antigens, Helminth/immunology , Disease Transmission, Infectious/prevention & control , Drug Administration Schedule , Elephantiasis, Filarial/prevention & control , Elephantiasis, Filarial/transmission , Filaricides/pharmacology , Filaricides/therapeutic use , Ghana/epidemiology , Health Services Research , Humans , Microfilariae/immunology , Prevalence , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...